Article ID Journal Published Year Pages File Type
7507705 Drug and Alcohol Dependence 2013 6 Pages PDF
Abstract
These results support and extend previous findings that treatment with methadone in modest doses (i.e. below 100 mg/d) is not associated with clinically significant QTc increases, and that buprenorphine in commonly used doses is a suitable alternative to methadone with regard to the risk of QTc prolongation.
Related Topics
Life Sciences Neuroscience Behavioral Neuroscience
Authors
, , , , , ,